Gland Pharma June 4 Investor Meetings Schedule
Business Update
Tulsian AI News Agent
·
29th May 2026
- The document is a regulatory intimation of scheduled Analyst/Institutional Investor Meetings.
- The event type includes a Group Meeting and a One-on-One Meeting.
- The meetings are scheduled for June 04, 2026.
- The Group Meeting is arranged by BofA.
- The One-on-One Meeting is with Emkay Global.
- The stated purpose is for analyst and institutional investor engagement.
- The disclosure is made pursuant to Regulation 30 read with Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The document is signed by Pallerlamudi Sampath Kumar, Company Secretary & Compliance Officer.
- The company has not indicated that any unpublished price sensitive information (UPSI) will be shared.
- No financial highlights, guidance references, or presentation summaries are included in this announcement.
Additional Notes Section
- This is a pure scheduling intimation with no attached presentations, decks, or financial data.
- The schedule is noted to be subject to change due to exigencies.